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The RET receptor tyrosine kinase is essential to
vertebrate development and implicated in multiple
human diseases. RET binds a cell surface bipartite
ligand comprising a GDNF family ligand and a
GFRa coreceptor, resulting in RET transmembrane
signaling. We present a hybrid structural model,
derived from electron microscopy (EM) and low-
angle X-ray scattering (SAXS) data, of the RET extra-
cellular domain (RETECD), GDNF, and GFRa1 ternary
complex, defining the basis for ligand recognition.
RETECD envelopes the dimeric ligand complex
through a composite binding site comprising four
discrete contact sites. The GFRa1-mediated con-
tacts are crucial, particularly close to the invariant
RET calcium-binding site, whereas few direct con-
tacts are made by GDNF, explaining how distinct
ligand/coreceptor pairs are accommodated. The RE-
TECD cysteine-rich domain (CRD) contacts both
ligand components and makes homotypic mem-
brane-proximal interactions occluding three different
antibody epitopes. Coupling of these CRD-mediated
interactions suggests models for ligand-induced
RET activation and ligand-independent oncogenic
deregulation.INTRODUCTION
RET is a single transmembrane-spanning receptor tyrosine
kinase (RTK) that plays critical roles in the development of
vertebrate central and peripheral (enteric) nervous systems, kid-
ney and Peyer’s patch organogenesis, and spermatogenesis
(Iba´n˜ez, 2013). RET is directly causal in several human diseases,1894 Cell Reports 8, 1894–1904, September 25, 2014 ª2014 The Auincluding Hirschsprung’s disease; congenital anomalies of the
kidneys or lower urinary tract; and multiple cancers, including
multiple endocrine neoplasia type 2A and 2B (MEN2A and
MEN2B) syndromes (Amiel et al., 2008; Mulligan, 2014; Schedl,
2007). RET is the primary signaling receptor for glial-cell-line-
derived neurotrophic factor (GDNF) family ligands (also known
as GFLs), which are soluble covalent dimeric ligands and mem-
bers of the cystine-knot superfamily (Airaksinen and Saarma,
2002). However, RET only recognizes GFLs bound to a member
of the GDNF receptor alpha (GFRa) family of glycosylphosphati-
dylinositol (GPI)-linked coreceptors (Treanor et al., 1996; Trupp
et al., 1996). There are four human GFLs: GDNF, artemin
(ART), neurturin (NTN), and persephin, which combine with four
human GFRa coreceptors to form cognate and noncognate
pairs. Each pair is capable of binding and stimulating RET auto-
phosphorylation at discrete tyrosine sites. This suggests a
remarkable molecular plasticity within RET receptor to accom-
modate this diverse set of ligands. The RET-GFL-GFRa complex
(the RET ‘‘ternary’’ complex) has a 2:2:2 stoichiometry and ex-
hibits positive cooperativity (Schlee et al., 2006).
The ligand-binding RET ectodomain (RETECD) contains four
consecutive cadherin-like domains (CLD1–CLD4) followed by a
membrane-proximal cysteine-rich domain (CRD) (Figure 1A).
RET CLD domains diverge significantly from classical cadherins
(calcium-dependent adhesion) in sequence, structure, and
arrangement (Anders et al., 2001; Brasch et al., 2012; Kjaer
et al., 2010). RETCLD1-2 forms a clamshell arrangement inmarked
contrast to the linear organization of tandem repeats of cadherin
domains (Kjaer et al., 2010). Calcium ions are critical for RET
folding consistent with the conservation of classical cadherin
calcium-coordinating motifs between CLD2 and CLD3 (Anders
et al., 2001; Kjaer and Iba´n˜ez, 2003a; van Weering et al., 1998).
Efforts to map the bipartite GDNF-GFRa1-binding site within
RETECD have implicated almost the entire RETECD region. Cross-
linking studies suggested that the CRD domain makes direct
contacts with both theGDNF ligand andGFRa1molecule (Amor-
esano et al., 2005). A separate study identified several regionsthors
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Figure 1. Architecture and Ligand Binding
Properties of zRETCLD1-4 and zRETECD
(A) RET domain organization, highlighting the
extracellular domain (ECD) and domain color
codes used throughout.
(B) Ligand binding properties of zRETECD,
zRETCLD1-4, and zRETCLD4-CRD. Purified recombi-
nant proteins were added to immobilized zGDNF-
GFRa1 in the presence of calcium (except lane 3).
Samples were visualized by Coomassie-stained
SDS-PAGE.
(C) SAXS data for the zRETCLD1-4. The solid line
shows the scattering curve calculated from the
RETCLD1-4 model shown in (D), with a c2 = 3.1.
(D) Ab initio SAXS reconstruction superimposed
with a model for RETCLD1-4 constructed as
described in the text.
(E) Ab initio SAXS reconstruction for RETECD
compared with the model for RETCLD1-4 produced
in (D). A potential location for the CRD domain
packing against CLD4 is indicated.within RETCLD1 that are important for ligand-coreceptor binding
whereas characterization of human/Xenopus RETECD receptor
chimeras implicated human RETCLD1-3 in restoration of binding
to both mammalian GDNF-GFRa1 and NTN-GFRa2 complexes
(Kjaer and Iba´n˜ez, 2003b). Structure-function analyses on
GFL-GFRa ligands have implicated residues within domains
D2 and D3 of GFRa in binding RET (Parkash et al., 2008; Wang
et al., 2006). These studies used structures of binary complexes
of GFL-GFRa that lacked the related domain D1, thought to
be dispensable for GDNF and RET binding (Scott and Ibanez,
2001).
Despite the importance of RET in vertebrate development
and disease, the molecular basis for RET recognition of its
bipartite GFL-GFRa ligands is not known. Here, structural
models for reconstituted mammalian (mTC) and zebrafish
(zTC) RET-GDNF-GFRa1 ternary complexes are presented
and further validated by a Fab-complex reconstruction by
zTC mutational assay and by probing monoclonal antibody epi-
topes in mTC. The flower-shaped structural model identifies
how a composite binding site in RET involving multiple CLD
domains and the CRD domain can accommodate multiple
GFL ligands and drives a homotypic interaction between mem-
brane-proximal regions of RETCRD. Ligand engagement may
organize CRD self-association triggering RET signaling, a prop-Cell Reports 8, 1894–1904, Seperty that is hijacked by crosslinking
oncogenic mutations found in MEN2A
patients.
RESULTS
Spatial Organization of the RET
Extracellular Domain
Recombinant zebrafish RET extracellular
domain (zRETECD) and cadherin-like do-
mains 1–4 (zRETCLD1-4) were prepared
using baculovirus-mediated protein ex-
pression in insect cells. By size exclusionchromatography coupled multiangle light scattering (SEC-
MALS), zRETECD and zRETCLD1-4 had apparent molecular
weights of 83.7 and 67.5 kDa, respectively (Figures S1A and
S1B). Partial deglycosylation of zRETECD and zRETCLD1-4 was
achieved with endoglycosylase F1, resulting in monodisperse
samples with reduced sugar content. To examine whether these
proteins were functional in vitro, zRETECD, zRETCLD1-4, and
zRETCLD4-CRD proteins were tested for binding to zGDNF-
zGFRa1a (referred to subsequently as zGFRa1) using a zTC
reconstitution assay (Figure 1B). Only zRETECD bound the ligand
complex and only in the presence of calcium. Shorter constructs
showed no detectable binding, indicating the entire RETECD is
required for ligand recognition similar to human RETECD (Kjaer
and Iba´n˜ez, 2003b).
To obtain information on the molecular shape of both
zRETECD and zRETCLD1-4 in solution, low-angle X-ray scat-
tering (SAXS) data were collected (Figures 1C, S1C, and
S1D). Pair distance distributions exhibited fine features consis-
tent with a multidomain protein sample. Ab initio envelopes
were generated for both zRETECD and zRETCLD1-4 using
DAMAVER consistent with the pair distance distributions.
Both showed an elongated shape and a similar radius of
gyration. Zebrafish RETECD data generated a twisted ‘‘horse-
shoe’’-shaped object whereas the RETCLD1-4 displays an ‘‘L’’tember 25, 2014 ª2014 The Authors 1895
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Figure 2. Electron Microscopy Reconstruc-
tion of a Reconstituted Mammalian RETECD-
GDNF-GFRa1 Ternary Complex
(A) Domain schematic for RETECD, GDNF, and
GFRa1 regions used to assemble mTC. The CRD
region is further divided into an amino-terminal
CRDN and carboxy-terminal CRDC portion (resi-
dues 591–627).
(B) SDS-PAGE of assembled recombinant mTC.
(C) Orthogonal views of themTC 3D reconstruction
at 24 A˚ resolution from negative-stain electron
microscopy. The surface representation encloses
a molecular weight of 264 kDa.
(D) Structural model for mTC generated by fitting
various domains into the EM map as described in
the text.
(E) Left: difference volume map (yellow) generated
after fitting all mTC components (as in D, but rep-
resented as surface), showing the inferred location
of the amino-terminal portion of the CRD domain
(CRDN). Right: the base density contains the
GFRa1 carboxy-terminal tail and carboxyl-termi-
nal residues from RETCRD prior to residue 635
(CRDC), indicated by red arrows.shape with a short and long arm with a wide ‘‘head’’ (Figures
1D and 1E). The addition of the CRD within RETECD did
not extend the maximum intramolecular vector length but
generated a ‘‘bump’’ adjacent to RETCLD4, which was tenta-
tively attributed to part of the CRD.
The zRETCLD1-4 structure was modeled using the human
RETCLD1-2 (hRETCLD1-2) structure (Protein Data Bank [PDB]
code 2X2U) and cadherin-based models for hRETCLD3/
hRETCLD4. The hRETCLD1-2 structure, with its distinctive clam-
shell shape, was recognizable at the wider end of the RETCLD1-4
envelope (Figure 1D). A model for the RETCLD3 domain was
placed relative to RETCLD2 by using a tandem classic cadherin
domain template (PDB code: 1LW3) to preserve both the
conserved calcium-coordinating ligand geometry (LDRE, DXD,
and DEDDmotifs; Figure S5C) and the presumed linear arrange-
ment of RETCLD2 and RETCLD3. A RETCLD4 domain model was
added to RETCLD1-3 with a bend angle of 100 consistent with
the ab initio SAXS envelopes. The final residuals from fitting
the theoretical curves derived from this RETCLD1-4 model against1896 Cell Reports 8, 1894–1904, September 25, 2014 ª2014 The Authorsthe experimental curves gave a c2 value
of 3.1, indicating a reasonable agree-
ment. The high-quality SAXS data were
therefore sufficient to generate prelimi-
nary models for RETECD and RETCLD1-4,
defining all pairwise CLD interdomain
angles and a potential location for the
CRD. The CLD2-CLD3 angle of 150 is
within the range observed for tandem
cadherin domains (130–170); however,
given the lack of calcium ligands between
CLD1-CLD2 and CLD3-CLD4, interdo-
main angles cannot be reliably predicted.
The SAXS model indicates the CLD1-
CLD2 clamshell resembles that of acalcium-free T-cadherin (Ciatto et al., 2010) whereas CLD3-
CLD4 angle of 100 means CLD4 projects away from the
CLD2-CLD3 principal axis.
Reconstitution of mTC and zTC RET-GDNF-GFRa1
Ternary Complexes
Two recombinant RET ternary complexes were assembled for
structural analysis. The mTC consisted of human RETECD (resi-
dues 1–635), rat GFRa1 (residues 1–427, removing the GPI-
attachment site), and mature human GDNF (residues 77–211;
Figure 2A; Supplemental Information). Previous studies showed
that hRETECD produced in a glycosylation-deficient Chinese
hamster ovary (CHO) Lec8 cell line binds to hGDNF-rat GFRa1
(rGFRa1) ligand with a Kd of 15 nM (Kjaer et al., 2010). No inter-
action between RETECD and hGDNF or rGFRa1 coreceptor
individually was detectable (data not shown). The mTC was re-
constituted in the presence of 1 mM calcium to give a pure
and monodisperse sample with a molecular weight of 343 kDa
by SEC-MALS (Figures 2B and S1E). The calculated molecular
weight of mTC, using a stoichiometry of two copies of RETECD:
two copies of GFRa: one GDNF dimer, was 260 kDa, suggesting
a substantial portion of the measured mass is contributed by
glycosylation.
Separately, a zebrafish ternary complex (zRETECD-zGDNF-
zGFRa1a) was also prepared consisting of zRETECD (residues
1–626), zGFRa1a (residues 1–352), and zGDNF (residues 135–
235; Figure S1F). These constructs were designed to truncate
the carboxy-terminal 120-amino-acid tail of zGFRa1 (referred
to as GFRa1delC) and the unstructured amino-terminal 46 amino
acids of mature zGDNF (referred to as zGDNFdelN). The compo-
nents formed a ternary complex (defined hereafter as zTCmin)
that shows a size-exclusion profile similar to mTC (Figure S1F).
However, by SEC-MALS, the zTCmin appeared less homoge-
neous than mTC, with molecular weights ranging from 200 kDa
to 420 kDa.
3D Reconstruction of a Mammalian RET-GDNF-GFRa1
Ternary Complex
The mTC complex was placed on electron microscopy (EM)
grids, negatively stained, and analyzed by single-particle
methods to obtain a 3D reconstruction. Molecular images of
mTC revealed a range of different orientations of the complex
and a good level of internal detail (Figure S2A). Reference-free
classification gave a range of class averages from which two
distinct views were extracted: (1) the ‘‘leg’’ view with two den-
sities branching from a more diffuse base (Figure S2B) and (2)
a ‘‘figure of eight’’ view (Figure S2B) with apparent 2-fold rota-
tional symmetry. The multivariate statistical analysis performed
on the complete non-rotationally aligned single particles data
set shows eigen images with 2-fold symmetry (Figure S2C). A
starting 3D model was built from two such classes assumed to
correspond to almost orthogonal orientations of the particle on
the grid. This initial model was further refined to produce the
EMmap shown in Figure 2C. The reliability of the map is attested
by the good agreement between classes and reprojections (Fig-
ure S2D) and the even distribution of Euler angles (Figure S2E).
The resulting map has a resolution of 24 A˚ as estimated by
Fourier shell correlation (Figure S2F). The mTC complex mea-
sures 190 A˚ in its longer dimension and is made up of two elliptic
domains (‘‘wings’’) when viewed down the 2-fold rotational axis
(Figure 2C, left), coalescing into a base domain (Figure 2C, right).
When the density map is contoured at a threshold chosen to
encompass amolecular weight of 264 kDa (calculatedmolecular
weight of mTC), the map generally has good connections be-
tween adjoining domains but lacks a connection between the
wings and the base. However, bridging density is visible when
the threshold used encloses a volume equivalent to a molecular
weight of 430 kDa and connects to the inner lobe of the base
(Figure S3A).
Generating an EM Structural Model for mTC
To construct an mTC structural model from the EMmap, coordi-
nates of the bipartite GFRa1D2-D3:GDNF dimeric ligand (PDB
code: 3FUB) were placed into the 3D reconstruction by aligning
the dyad symmetry axis of the GDNF-GFRa1D2-D3 crystal struc-
ture with the 2-fold symmetry axis of the EMmap. Only one of the
two possibilities gave a good fit with the EMmap, namely GDNFCell Reclosest to the base (as opposed to GFRa1D2-D3 toward the base;
Figure 2D, right-hand view). This placed the bipartite ligand at the
center of themTC complex (Figure 2D). Next, RETCLD1-4 could be
readily identified on the outside (the wings) of the 3D reconstruc-
tion using the knowledge of the SAXS-derived model (Fig-
ure S3B). Fitting the RETCLD1-4 SAXS-derived model into the
EM 3D reconstruction closely preserved the interdomain CLD
angles observed for RETCLD1-4. The theoretical SAXS scattering
curves derived from the EMmodel of hRETCLD1-4 fit the observed
SAXS curves better than the SAXS-derived zRETCLD1-4 model
(Figure S3C). This validated the SAXS model and confirmed
the identity of this region of the EM 3D reconstruction. Finally,
a homology model of the GFRa1D1 domain (derived from
GFRa3D3) was placed into a prominent density adjacent to
RETCLD1-2 and next to GFRa1D2-D3 (Figure 2D). This gave a
good fit and match to the estimated volume calculated from the
D1 domain sequence. The L-shaped GFRa1D1 domain was ori-
ented to place a conserved N-linked glycosylation site into sol-
vent rather than in an opposite arrangement that would place
the glycosylation site in an interface with GFRa1D3. The D1
domain placement is made with lower confidence than the rest
of themTC structuralmodel due to this independent fit and orien-
tation into the EM map (see Supplemental Information for a
description). It gives aGFRa1 domain organizationwithGFRa1D3
flanked by both GFRa1D1 and GFRa1D2. The long, highly
conserved D1-D2 linker most likely wraps around one side of
GFRa1D2D3. Overall, a correlation coefficient (CC) of 0.84 be-
tween the mTC structural model at 24 A˚ with the EM map was
indicative of the good agreement between model and density
(RETCLD1-4: CC = 0.87, GDNF-GFRa1D2-D3: 0.79, and GFRa1D1:
0.79). TheEMmapwas therefore sufficient to developastructural
model for the mammalian RET ternary complex containing either
known or readily modeled mTC domain structures.
Regions in the mTC map density not included in the structural
model are shown in a difference density map (yellow surface,
Figure 2E; Table S1). This map was calculated by subtracting
the density for the structural model low-pass filtered to a resolu-
tion of 25 A˚ from the mTCmap density. Two regions are evident:
a globular density sandwiched between CLD4 and GFRa1D2-
GDNF ligand (seen in Figure 2E, left panel) and a detached
‘‘base’’ region (Figures 2C and 2E, right panel). The first region
is bilobal, the larger lobe forms part of a ‘‘shared’’ GFRa1D2-
GDNF RET interface as described later. The smaller lobe pro-
jects toward the central density of the base region containing
the 2-fold axis (Figure 2E). This difference map volume was esti-
mated to correspond to about 12 kDa, leading to the assignment
of the RETCRD domain (CRDN; residues 509–600; Table S1) to
this density consistent with its location close to the RETCLD4,
as suggested by the SAXS envelope for RETECD (Figure 1E).
The base region from the EM map has an inner volume around
the 2-fold axis flanked by symmetry-related external volumes.
Either could potentially contain the N terminus of mature hGDNF
(residues 1–39; known to be unstructured), the C-terminal tail of
GFRa1 (residues 353–427), or the C-tail of hRETCRD (CRDC;
residues 601–635). The inner volume of the base region was
tentatively assigned to the C-tail of RETCRD based on volume
estimates (Table S1) and the weaker connecting density
observed at lower thresholds (Figure S3A, right panel). Thisports 8, 1894–1904, September 25, 2014 ª2014 The Authors 1897
Figure 3. mTC Structure Validation Using
Antibody Epitope Mapping
(A) Location of epitopes for four monoclonal anti-
bodies mapped against hRETECD (see Figure S4).
The 1D9 monoclonal binds a conformational
epitope within the CLD3-CLD4 linker and CLD4.
Monoclonals mAb 421R25, mAb 93A, and mAb
123 recognize short linear epitopes within the
hRETCRD.
(B) ELISA assay to assess the accessibility of
antibody epitopes in unliganded RETECD and the
mTC complex. Antibodies were added to wells
coated with GDNF-GFRa1-Fc (GG), human RET
ternary complex (TC), RETECD alone (RET), and
no protein control (blank). Error bars were calcu-
lated from the SE of the measurements. Three
independent measurements were obtained per
experiment.
(C) Left: orthogonal views of the 1D9 Fab-mTC EM
reconstruction (mesh) showing fitting of the mTC
EM reconstruction (beige surface) bound to two
1D9 Fabs (red surface). The Fab fragments were
docked into the additional apical density at CLD3-
CLD4, validating the mTC structure interpretation.
Right: reference-free class averages of the mTC-
1D9 Fab complex are shown (top row) with the
matching forward projections of the mTC recon-
struction (bottom row).would indicate that the bottom of the base lies adjacent to the
plasma membrane. The flanking outer base density (Figure 2E,
right panel) was then assigned to the 120-residue C-tail of
GFRa1. This interpretation is consistentwith theRETCRDC-termi-
nal residuesbeing incloseproximity, allowing theRET transmem-
brane helices (residues 636–660) to homodimerize as previously
shown (Kjaer et al., 2006). Relaxing the C2 symmetry applied to
mTC revealed some asymmetry in the base region but did not
markedly change the main core of the mTC (Figure S3D).
In parallel to the mTC EM reconstruction, a data set was
collected for the zTCmin complex containing 7,510 particles
using similar conditions to the mTC. The stability of the zTCmin
on EM grids was not as good as mTC, so the sample was cross-
linked using glutaraldehyde to improve the sample homogeneity
(Strauss and Wagenknecht, 2013). zTCmin-refined class aver-
ages and their corresponding reprojections closely resembled
those obtained for mTC (Figure S3F). A 3D reconstruction for
zTCmin calculated using the mTC model as reference contained
the same overall architecture for the ligand/coreceptor/
RETCLD1-4 with density for the D1 and CRD domains, but impor-
tantly, it lacked density for the base region (Figure S3G). This is1898 Cell Reports 8, 1894–1904, September 25, 2014 ª2014 The Authorsconsistent with the assignment of the
C-terminal 120-residue tail of zGFRa1
within the base region, where it contrib-
utes to base stability.
Validation of themTCEMStructural
Model
To further validate the mTC structural
model, four anti-RETECDmonoclonal anti-
bodies were characterized and their hu-man RETECD epitopes mapped by either immune blot or by im-
mobilized peptide arrays (see Figure S4 for epitope mapping),
summarized in Figure 3A. The monoclonal antibody (mAb) 1D9
antibody previously described (Salvatore et al., 2002) has a
conformation-sensitive structural epitope between RETCLD3
and RETCLD4-CRD. An ELISA assay indicated that the epitope
was accessible within both hRETECD and the mTC complex (Fig-
ure 3B). In contrast, three other antibodies were found to have
linear epitopes within the hRETCRD, which could be recognized
in a RETECD context, but not within the mTC complex (discussed
later). Therefore, Fab fragments derived from the mAb 1D9 were
used to obtain an EM reconstruction of a Fab-labeled mTC com-
plex. This complex was prepared and applied to EM grids in the
samemanner as themTC alone. The Fab 1D9-labeledmTC sam-
ple gave rise to distinctive reference-free classes (Figure 3C,
right panel), which were matched with references consisting of
forward projections calculated from the mTC alone map. The re-
sulting reconstruction showed good density consistent with two
symmetrically bound 1D9 Fabs that mapped accurately to the
density assigned to RETCLD3 and RETCLD4 on the exterior of
the wings (Figure 3C). This demonstrated that the wing was
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Figure 4. Bipartite Ligand Recognition by
hRETECD Shows a Composite Binding Site
(A) Contact surfaces within the EM structural
model for mTC labeled with the EM map super-
posed (beige). Right panel: schematic of the con-
tact sites within RET.
(B) Left panel: close up of site I and site II. Bold
black line roughly delineates the contact surface.
Right panel: close up of site III.
(C) Left panel: close up of the shared GDNF-
GFRa1 contact surface highlighting the difference
volume assigned to the CRD domain (yellow).
Right panel: close up of the base region difference
volume (yellow) assigned to CRD and GFRa1
C-tail.correctly assigned to RETECD and was correctly oriented. Valida-
tion of themTCmodel allows a proper description of the arrange-
ment of its component parts and confirms the placement of the
plasma membrane at the bottom of the view of mTC in Figure 2E
(right-hand panel).
A Composite Binding Site for Bipartite Ligand within the
mTC Structure
The mTC structural model reveals how GDNF-GFRa1 ligand is
captured by RETECD and drawn into close proximity to the mem-
brane (Figure 4A). It also shows that the major RETECD contacts
are with theGFRa1 subunit and RETECDmakes very limited inter-
actions with GDNF ligand. There are four major heterotypic con-
tact sites (i.e., between bipartite ligand and RETECD) within the
mTC structure, defined hereafter as sites I, II, III, and the fourth
as a shared ligand/coreceptor site. The sites are designated
from the RETECD amino terminus to carboxy-terminal residue
R635 and are discussed in more detail below. It is notable that
sites I, II, and III contact RETCLD1-3, consistent with the extended
ligand-binding surface proposed from human/Xenopus chimeric
RET experiments (Kjaer and Iba´n˜ez, 2003b). A fifth heterotypic
site is inferred between GFRa1 C-tail and RETCRD within the
mTC base region, together with a homotypic RETCRD interaction
that is discussed later. The contact surfaces are separated by
substantial cavities within the mTC, and some regions, such
as RETCLD4, appear to make no direct contacts to ligand-
coreceptor at all.Cell Reports 8, 1894–1904, SepBoth sites I and II involve RETCLD1, the
most divergent RET CLD, which contains
residues and secondary structural ele-
ments previously identified as being
unique to higher vertebrates (Kjaer et al.,
2010). RETCLD1 is pincered by indepen-
dent contacts from loop1 of GFRa1D1
(site 1—lower confidence, as discussed
earlier) and loop1 from GFRa1D3 (site
II—high confidence; Figures 4B and
S5A). Neither of these loops contains
invariant GFRa residues, and the GFRa4
family member lacks a domain D1 alto-
gether. The GFRa1D1 contact centers on
residues separating the CLD1 ßF strandand the cis-Pro disulfide-constrained loop. This sequence was
disordered within the isolated CLD1-CLD2 structure. GFRa1D3
engages both a loop that follows RETCLD1 helix a1 and b strands
ßC’/ßC’’ (Figure 3B). In site II, GFRa1D3 loop 1 is known to be flex-
ible, as it adopts different conformations in two GDNF-GFRa1
structures (PDB codes: 2V5E and 3FUB). Site III is a high-confi-
dence site from the mTC structural model. It contains conserved
residues N-X-X-E/D-E/D motif between loop 3 and a10 helix of
GFRa1D3 and several regions proximal to the calcium-binding
site between RETCLD2 and RETCLD3 (Figures 4B and S5C).
GFRa1D3 loop 3 is flanked by two disulfide-linked cysteines
and is significantly longer than equivalents in domains D1 and
D2. Similarly, contactswithin RETECD lie spatially close to the cal-
cium-binding motifs D-E-D-D and E-N (Figure S5C). A second
loop in RETCLD3 adjacent to the D-X-D motif also faces toward
the GFRa1D3 surface. Contacts close to these calcium ligands
are even more intriguing because calcium is essential for mTC
assembly, an observation previously interpreted to reflect cal-
cium’s structural role in RETECD stability. The shared site (high
confidence) consists of surfaces from both protomers of the
GDNF dimer as well as loop1 from GFRa1D2 (Figure 4C). These
regions face toward the larger difference density lobe interpreted
as containing part of RETCRD. The GDNF site involves residues
G54–E58 (GLGYE) from a1 helix of one protomer and the edge
of the GDNF ‘‘fingers’’ from the second protomer (Figure S5B).
Loop1 from GFRa1D2 spans residues C178–C189 between heli-
cesa2 anda3 and are generally poorly conserved amongGFRas.tember 25, 2014 ª2014 The Authors 1899
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Figure 5. Mutational Analysis Identifies a
Crucial RET-Binding Hotspot within GFRa1
Adjacent to theRETCLD2-CLD3Calcium-Bind-
ing Region
(A) Location of residues chosen for mutation within
the zGDNF-zGFRa1 complex. N-linked glycosyl-
ation sites were added or deleted within each
contact site to perturb binding, except for site III,
which was tested by a triple-point mutation.
Mutants were assessed for their ability to recon-
stitute a functional zTC in the presence of calcium.
(B) Quantification of zRETECD binding to immobi-
lized zGFRa1-zGDNF or mutant complexes. Three
to four independent experiments were performed
for each mutant, using three to four separate
protein preparations. Nonspecific RETECD binding
was assessed in the absence of calcium and
was <5% of total binding. The N186D zGDNF
mutant was misfolded but is included to show
no detectable binding to zRETECD occurs in the
absence of zGDNF. Error bars were calculated
using the SEM from three to four independent
experiments.
(C) Close up of the site III contact, highlighting the
three residues mutated that are crucial for mTC
assembly.To probe the contribution of the mTC contact regions on RET
ternary complex assembly, N-linked glycosylation sites (N-X-
S/T) or point mutations were introduced or deleted within
zGDNF ligand or zGFRa1 and assessed in a zTCmin reconstitu-
tion assay (Table S2). The zTCmin context was more amenable
to a structure-function mutation analysis than mTC, given the
complexity of producing mTC components in stable CHO cell
lines. Mutations in zGDNF ligand or zGFRa1 coreceptor were
designed to sample each of the four contact surfaces through
surface loops or structural elements (Figure 5A). They were
tested for their ability to bind equivalent levels of zRETECD
and reconstitute a zTCmin complex. Residues tested were
mostly conserved between zGFRa1-zGDNF and hGFRa1-
hGDNF (Figure S5). The mutant zGFRa1-zGDNF proteins ex-
hibited very different effects on zTCmin complex formation
(Figure 5B). A triple-alanine mutation in site III of zGFRa1
(N323A/E326A/E327A) adjacent to the CLD2-CLD3 calcium-
binding site essentially abolished interaction with zRETECD (Fig-
ures 5B and S6). A site II mutation (S276N) introducing a
glycosylation site also significantly reduced binding by 60%.
A loop2D3 mutant (L305S) also had a markedly lowered affinity
for zRETECD. Addition of a glycosylation site in loop1D2 of
zGFRa1 (R180N), located within the shared ligand/coreceptor
site, actually increased affinity to 130%. Mutations that
removed existing N-linked glycosylation sites from either
zGDNF (N150D) at the shared site or at the site I interface
with GFRa1 (N62D) had essentially wild-type binding consistent
with previous studies, indicating sugar is not essential for
complex assembly (Kjaer and Iba´n˜ez, 2003b). Loss of these
N-linked sites could be observed by SDS-PAGE (Figure S6).
Overall, these data indicate that site II and site III mutations
impact significantly on zRETECD binding affinity.1900 Cell Reports 8, 1894–1904, September 25, 2014 ª2014 The AuCRD Is Buried within mTC and Couples Ligand
Recognition with Receptor Self-Association
In the mTC structural model, the CRD domain participates in
both a shared ligand/coreceptor contact surface and a homo-
typic interaction with a second CRD domain apparently stabi-
lized by a flanking C-tail from the GFRa component. To
investigate the RETCRD further, three anti-hRETECD antibodies
whose linear epitopes were mapped to the CRD were used to
probe epitope accessibility within mTC (Figure 3A). Antibody
mAb 421R25 was found to recognize a linear epitope within
hRETECD that mapped to residues 540–545 (RCEWRQ) in the
amino-terminal part of RETCRD (Figure S4). This epitope mapped
to part of the hRETCRD packed against CLD4 and the shared site
contacting GDNF-GFRa1 (Figure 2E). Using an ELISA-based
assay, the mAb 421R25 epitope was found to be inaccessible
within the mTC but exposed in hRETECD, indicating that this
part of the CRD is buried upon ligand engagement (Figure 3B).
A second antibody mAb m123 produced in house recognized
a linear epitope containing residues 600–604 (RGIKA) from
hRETCRD (Figure S4). This portion of hRETCRD is in the C-terminal
tail of CRD (residues 600–635) buried within the homotypic
hRETCRD interface of the base region (Figure 4C). This CRD
epitope was found to be exposed to mAb m123 within hRETECD
but is blocked within mTC (Figure 3B), consistent with the CRD
C-tail being buried within the mTC complex. A third antibody,
mAb 93A (also produced in house), recognized a linear hRETCRD
epitope containing residues 630–634 (CDELCR) at its most
membrane-proximal extremity (Figure S4). This epitope is also
masked within the mTC (Figure 3B). Intriguingly, this antibody
does not bind the epitope in the presence of reducing agents,
indicating that it selectively recognizes a C630-C634 disulfide
epitope (Figure 6A). Therefore, evidence from three differentthors
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Figure 6. A Membrane-Proximal CRD Region Mediates Homotypic Interactions Driven by RET Ligand Engagement
(A) Western blot analysis of mAb 93A binding to a hRETECD disulfide epitope (residues 630–635) in the presence or absence of reducing agents. Load from left to
right was 0.5 mg, 0.25 mg, 0.125 mg, 0.0625 mg, and 0.031 mg hRETECD. DTT, dithiothreitol.
(B) SDS-PAGE gel of a pull-down of zRETECD or zRETECD-DC using immobilized zGDNF-GFRa1, showing enhanced binding in the absence of residues 591–627.
Gel quantification indicates 135% ± 10% relative to normalized binding by zRETECD. Three independent experiments were performed.
(C) Selected RETCRD sequences close to the transmembrane region, highlighting the cysteine residues targeted for oncogenic mutation in MEN2A/FMTC and the
location of antibody epitopes for mAb 93A and m123.
(D) A schematic model for bipartite ligand (green, labeled L) interaction with RET, promoting homotypic dimerization of the RET CRD domain and activation. The
GFRa1 tail contacts with CRD are omitted for clarity.antibody epitope probes consistently indicates that the CRD is
fully accessible within hRETECD but is entirely buried within the
mTC, up to and including its C-terminal residues prior to the
transmembrane region.Cell ReTo examine the ability of CRD to promote homotypic RET
self-association independent of ligand, both hRETECD and
hRETECD MEN2A (C634R), the most common RET mutation
found in MEN2A patients (thought to generate crosslinkedports 8, 1894–1904, September 25, 2014 ª2014 The Authors 1901
disulfide-linked dimers), were examined for evidence of dimer-
ization in solution. However, neither hRETECD nor hRETECD
MEN2A (C634R) spontaneously formed dimers, even at high
concentrations (Figure S1B; data not shown). To test whether
the RETCRD C-terminal region influenced ligand interaction, res-
idues 591–627 were deleted from zRETECD (zRETECD-DC), and
this construct was tested in the in vitro pull-down assay (Fig-
ure 6B). Elimination of residues 591–627 significantly enhanced
binding to zGDNF-GFRa1 (135% relative to normalized binding
to wild-type zRETECD), indicating CRD homotypic interactions
reduced the overall binding affinity for zGDNF-GFRa1 complex.
This suggests that bipartite ligand binding must overcome resis-
tance to self-associate mediated by the RETCRD C-terminal re-
gion (CRDC). Overall, these data provide evidence that ligand
recognition serves to crosslink two RETECDmolecules driving re-
ceptor self-association between CRD domains and most likely
the transmembrane helix.
DISCUSSION
The RETECD organization described here indicates a substantial
interdomain interface not only between domains CLD1 and
CLD2 but between CLD4 and CRD. Both interfaces are consis-
tent with observed mutual folding dependencies for each
domain pair (i.e., they only fold correctly when expressed
together; Kjaer and Iba´n˜ez, 2003a). Interdomain angles for RET
deviated significantly from those previously predicted (Anders
et al., 2001), except for the CLD2-CLD3 angle, which resembles
a classical calcium-binding cadherin arrangement. The SAXS-
derived model for RETECD aided an EM-derived structural model
of a reconstituted mammalian RET-GFRa1-GDNF complex
(‘‘RET ternary complex,’’ abbreviated mTC), revealing the basis
for bipartite ligand recognition. The mTC structural model was
validated in several ways. These include EM single-particle re-
constructions of a Fab-labeled ternary complex and a RET
ternary complex from Danio rerio (zTC), together with site-spe-
cificmutational analysis and an ELISA probing anti-RET antibody
epitope accessibility.
The mTC structural model reveals that the GFL ligand is
captured beneath the GFRa coreceptor, close to the membrane.
RETECD wraps around and shields both the GFL ligand and
coreceptor rather than projecting away from the plasma mem-
brane. Limited contacts observed between RET and GFL ligand
could accommodate any of the four GFLs when combined with a
GFL-dimerized GFRa component. The mTC structural model
rationalizes several previous studies indicating all RETECD do-
mains are required for a functional GDNF-GFRa1-binding site.
The explanation is a synergy of distributed binding hotspots
with mutual domain-folding dependencies. A binding hotspot
between CLD2 and CLD3 is necessary (but not sufficient) to
engage bipartite ligand, whereas the CRD is also required but
is not sufficient for mTC assembly. CLD1 is essential for CLD2
folding, and CLD4 is required for CRD folding. Combining both
RETECD domain-folding dependencies with the location of
ligand-binding hotspots prevents any single domain being
dispensable for ligand interaction. The observed composite
ligand-binding site contrasts sharply with other RTK-ligand
structures that show a much more continuous, often domain-1902 Cell Reports 8, 1894–1904, September 25, 2014 ª2014 The Auconfined, surface to engage ligands (Lemmon and Schlessinger,
2010). It is more analogous to cytokine-receptor systems where
individual cytokines have specialized receptors, a shared/
common signaling receptor component, and composite binding
sites (Stauber et al., 2006;Wang et al., 2005). Furthermore, these
systems also offer precedents for the recognition of divergent
ligands, such as the degenerate gp130 receptor that recognizes
ciliary neurotrophic factor, leukemia inhibitory factor, and inter-
leukin-6 cytokine ligands (Boulanger et al., 2003). The mTC
structure suggests an unusual RTK recruitment mechanism
more akin to cytokine-receptors complexes but driven by core-
ceptor GFRa1 engagement.
The mTC structural model also explains how hRETCLD1-3 con-
fers hGDNF-hGFRa1 binding specificity onto a human/Xenopus
RETECD chimera by preserving determinants for sites I, II, and III
whereas permitting the self-associating CRD to come from a
Xenopus RET origin (Kjaer and Iba´n˜ez, 2003b). Binding determi-
nants for hGDNF-hGFRa1 binding within CLD1 are particularly
important (Kjaer and Iba´n˜ez, 2003b). Satisfyingly, all but one of
these CLD1 determinants appears to contribute directly to
ligand-binding sites I/II/III in the mTC structural model (Figure 3).
The exception is the amino-terminal b strand (residues 32–37)
that is buried within the CLD1-CLD2 interface (Kjaer et al.,
2010). Despite the composite nature of the interaction, a critical
and conserved GFRa-binding energy ‘‘hotspot’’ is identified at
site III, involving the motif N-X-X-E/D-E/D from domain D3. The
GFRa contacts lie adjacent to the hRETECD calcium-binding
site between CLD2 and CLD3. This suggests the calcium depen-
dence is not only crucial for RET folding but is also critical for
ligand recognition, a feature that has been previously over-
looked. Evolutionary pressure to preserve calcium ligands in
RET only between CLD2 and CLD3 may reflect a need to retain
a functional ligand-binding site. Previous studies predicted a
RET-binding site based on an ART-GFRa3 structure but lacked
supporting experimental evidence (Wang et al., 2006) or identi-
fied many potential RET-binding residues from different regions
of the GFRa1 coreceptor (Parkash et al., 2008). These data need
revisiting in view of the EM structural model described here. For
example, GFRa1 D3 residues R190/R197, R257/R259, and
K194/Q198/K202 (human GFRa1 numbering) were all implicated
in RET binding but map to an interface with the GFRa1 D1
domain in the EM structural model. These residues constituted
a putative heparin-binding site, leading the authors to suggest
that heparin could inhibit RET signaling by binding to this sur-
face. Alternatively, perturbing the D1 interface could affect RET
engagement. Other residues such as E323/D324 (equivalent to
zRET E326/E327, the site III hotspot) were correctly proposed
but only now have a proper understanding as to how they con-
tact RET (Parkash et al., 2008; Wang et al., 2006).
Probing three separate RETCRD epitopes with different mono-
clonal antibodies indicates they are buried within the mTC com-
plex. The different locations of these RETCRD epitopes, two
within CRDC (CDELCR and RGIKA), suggested that joint
recognition of coreceptor and ligand promotes RETCRD C-tail
self-association, assisted in part by the C-tail of GFRa1. The
RETCRD C-tail homotypic interaction is the only source of direct
dimerization contacts visible between RET dimers in the mTC.
Deleting the CRDC increases ligand interaction, suggesting thethors
membrane-proximal region of RET may negatively influence
ternary complex formation. It could act as a failsafe to block
inappropriate ligand-independent receptor activation, similar to
findings reported for the VEGFR2 receptor tyrosine kinase
(Brozzo et al., 2012). EM class averages suggest the RETCRD is
a relatively flexible region that is discernably separated from
the core of the mTC complex. Previous data showed a strong
self-association of the hRET transmembrane region (Kjaer
et al., 2006), placing a tight constraint that the last CRD domain
residue, R635, that precedes the transmembrane regionmust be
in close proximity to a second RET receptor in the ternary com-
plex. The absence of a base region in zTCmin containing a GFRa1
C-tail truncation mutant uncovers a detectable but noncritical
role for the GFRa1 C-tail in zTC assembly, warranting further
characterization.
Ligand-driven self-association of RETCRD within mTC may
account for the observed positive cooperativity (>80-fold) for re-
cruiting a second RET molecule into the ternary complex after
ligand engagement (Schlee et al., 2006). This is consistent with
a stepwise assembly of mTC. RETCRD C-tail self-association is
also fatally exploited in oncogenic forms of RET in MEN2A pa-
tients. Many RET mutations found in MEN2A patients lie in the
C-terminal region prior to the membrane (C609Y/W, C611S/W,
C618S/R/G/F/Y, C620R/W/F/S/Y, C630F, and C634R/W/F/S/
Y/G; see Figure 6B), the most common being C634R at the
end of hRETCRD (Waguespack et al., 2011). This mutant readily
forms disulfide adducts in cells, leading to constitutive RET acti-
vation (Santoro et al., 1995). Covalent crosslinking of CRDC
would potentially bypass a ligand requirement for self-associa-
tion. However, neither hRETECD nor its MEN2A equivalents
form covalent or noncovalent dimers in solution. This can be
rationalized by the lack of a cell membrane environment (3D
versus a 2D diffusion), as the RET transmembrane region in
known to promote self-association (Kjaer and Iba´n˜ez, 2003a;
Kjaer et al., 2006). Alternatively, it could also be explained by a
ligand-dependent conformational change within RETCRD (Fig-
ure 6C). Such an allosteric model would require engagement of
all four RET contact sites by ligand and coreceptor in order to
reorient CRD correctly to promote self-association and activa-
tion. Whether such ligand-driven changes can alter the arrange-
ment of RET transmembrane dimers requires investigation but is
plausible. Although RETCLD1-4 does not appear to grossly alter its
conformation on ternary complex formation (comparing the
SAXS-derived and EM-derived RETECD model; Figure S3C), the
CRD domain conformation appears more labile and could be
susceptible to conformational changes. The mTC structural
model and knowledge of antibody epitopes buried within the
mTC suggests that specific reagents targeting the RETCRD
may have therapeutic application in a subset of RET-driven
cancers.
EXPERIMENTAL PROCEDURES
Protein Production and TC Assembly
Human RETECD (residues 1–635; hRETECD) was expressed in stably trans-
fected CHO Lec8 cells as a cleavable protein A fusion protein as described
in Kjaer et al. (2010). Rat GFRa1 (residues 19–427, following signal sequence
cleavage; rGFRa1) was also expressed in CHO cells. Mature human GDNF
(residues 77–211; hGDNF) was from Amgen. For mTC assembly, excessCell RehGDNF was added to immobilized rGFRa1 with purified hRETECD added sub-
sequently. The mTC was eluted by tobacco etch virus protease cleavage and
was subsequently purified by size-exclusion chromatography. Zebrafish
RETECD (residues 1–626) and zRETCLD1-4 (residues 1–502) were produced
in insect cells as recombinant baculoviruses with a protein A tag using stan-
dard protocols. Zebrafish GFRa1a (residues 1–352) and zGDNF (residues
135–235) were prepared in the same manner. For zTC assembly, a similar
protocol to mTC was followed with a final size-exclusion chromatography
purification step.
SAXS Data Collection and Processing
SAXS data were collected on the SWING beamline at synchrotron SOLEIL.
Data were processed using both in-house and external SAXS software (see
Supplemental Experimental Procedures). Data fitting used GNOM (Svergun,
1992) and ab initio models came from DAMMIF (Franke and Svergun, 2009)
and DAMAVER (Volkov and Svergun, 2003).
Epitope Mapping of mAbs and ELISA to Measure mAb Epitope
Accessibility
The locations ofmAb epitopes recognized within hRETECDwere determined by
either immuno-dot-blotting (for 1D9) or by peptide arrays spotted onto cellu-
lose membranes (m123, 93A, and 421R25). An ELISA assay was employed
tomeasure antibody binding to hRETECD, GDNF-GFRa1, or mTC as previously
described (Kjaer and Iba´n˜ez, 2003b).
Electron Microscopy and Single-Particle Analysis Methods
Molecular images of the mTC and zTCmin complexes were recorded after
negative staining using an FEI Tecnai TF20 electron microscope operating at
200 kV and were used to determine the 3D structures by single-particle anal-
ysis procedures. A structural model of the mTC complex was built by fitting
atomic coordinates from published crystal structures and the SAXSmodel ob-
tained in this study. Further details are given in the Supplemental Information.
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